This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.
This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.
This webpage provides information on early HIV-related mouth sores, including pictures to help with identification. It discusses common oral symptoms associated with early HIV infection, such as ulcers, thrush, and other lesions, and highlights their significance in early diagnosis.
This article discusses how the U.S. Preventive Services Task Force has proposed new draft guidelines for cervical cancer screening, allowing women aged 30 and older to self-collect HPV samples. This approach aims to improve access to screening, particularly for Black and Hispanic women. The guidelines recommend HPV testing every five years for women aged 30 to 65, alongside traditional Pap tests, and the self-collection method is expected to increase screening rates by offering a more comfortable option.
This webpage offers information on syphilis and its causes, symptoms, and treatment options.
This webinar is about improving maternal health lessons learned from states addressing congenital syphilis.
This doxy PEP infographic poster covers what the general public needs to know about doxy PEP.
The doxy PEP action kit is a toolkit that provides resources for patients and providers on doxy PEP.
More than 2.4 million cases of chlamydia, gonorrhea, and syphilis were reported in the U.S. in 2023. Still, the numbers show the cases of reportable STIs tended to decrease, or at least saw a sharp decline in the rate by which they increased. In this episode of the Sex+Health podcast, we talk with Bradley Stoner, MD, PhD, the Director of the Centers for Disease Control and Prevention Division of STD Prevention, for his thoughts on what's driving the epidemic and why the latest data show there may be cause for optimism.
Sexually Transmitted Infections Surveillance, 2023 provides the most current and complete data for three nationally notifiable STIs: chlamydia, gonorrhea, and syphilis, including congenital syphilis.
